Formerly About Advanced Micro Devices Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: bentway who wrote (889611)	9/22/2015 8:47:44 PM
From: combjelly	Read Replies (1) of 1576368

They also need to streamline the FDA requirements for clinical and animal trials. *Part 1: Phase III Trials Are driving Rising Costs in Medical Innovation* In 1975, the pharmaceuticals industry spent the equivalent of $100 million in today’s dollars for research and development of the average drug approved by the U.S. Food and Drug Administration, according to the Tufts Center for the Study of Drug Development. By 1987, that figure had tripled, to $300 million. By 2005, this figure had more than quadrupled, to $1.3 billion. manhattan-institute.org They also need to modify the requirement that an MD is to lead the trials. MDs usually don't have the training or the right mindset to do research. So they way too often cheat. There was one case where a new drug was in its first trial on humans. They had to stop it almost immediately because the drug killed the livers of the patients. Come to find out the doctor doing the animal study didn't actually do a study. He made up all of the results. So, have a doctor on staff. Give them the authority to shut the study down. Just don't let them touch the data.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next